• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-038
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Ventricular Tachycardia (2132); Cardiogenic Shock (2262); Prolapse (2475)
Event Date 12/23/2014
Event Type  Injury  
Event Description
The patient's history was positive for two infarcts and cardiogenic shock at the time a ventricular septal defect closure (vsd) was scheduled.In the medical opinion of the physician, vsd occluders were not suitable and the physician opted to use a 38mm amplatzer septal occluder (aso).At the time of implant, the aso prolapsed into the right ventricle as it was too small for the defect.During the procedure, the patient experienced ventricular tachycardia and required multiple defibrillations and the procedure was aborted.The patient was stabilized.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The 38mm aso was returned to sjm and decontaminated.The occluder was grossly and microscopically examined, and no anomalies were found.It met dimensional specifications when measured with a caliper.The aso was loaded into a test loader, deployed and retracted without difficulty or deformation, under non-physiological conditions.The results of this investigation confirmed the aso met all functional and dimensional specifications when analyzed at sjm.There was no evidence to suggest there was an intrinsic defect in the occluder, and the cause of the reported prolapse remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4402484
MDR Text Key16306195
Report Number2135147-2015-00002
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date06/30/2015
Device Model Number9-ASD-038
Device Catalogue Number9-ASD-038
Device Lot Number1007014569
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/23/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/21/2010
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient Weight72
-
-